Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rinella

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Minerva Chirurgica|June 15, 1985
[Carcinoma of the gallbladder]G Vadalà, P Rinella, A Buffone, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Combination fedratinib and venetoclax has activity against human B-ALL with high FLT3 expressionSean P Rinella, Haley C Bell, Nicholas J Hess, et al.
Leukemia & Lymphoma|April 12, 2021
CXCR4 allows T cell acute lymphoblastic leukemia to escape from JAK1/2 and BCL2 inhibition through CNS infiltrationKirsti L Walker, Sean P Rinella, Nicholas J Hess, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
TIM-3 blockade enhances ex vivo stimulated allogeneic NK cell therapy for relapsed murine neuroblastoma after hematopoietic cell transplantAicha Quamine, Nicholas R Mohrdieck, Chloe A King, et al.
Journal for Immunotherapy of Cancer|December 12, 2025
TIM-3 blockade enhances ex vivo stimulated allogeneic NK cell therapy for relapsed murine neuroblastoma after hematopoietic cell transplantAicha E Quamine, Evan L Dray, Nicholas R Mohrdieck, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Minerva Chirurgica|June 15, 1985
[Carcinoma of the gallbladder]G Vadalà, P Rinella, A Buffone, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Combination fedratinib and venetoclax has activity against human B-ALL with high FLT3 expressionSean P Rinella, Haley C Bell, Nicholas J Hess, et al.
Leukemia & Lymphoma|April 12, 2021
CXCR4 allows T cell acute lymphoblastic leukemia to escape from JAK1/2 and BCL2 inhibition through CNS infiltrationKirsti L Walker, Sean P Rinella, Nicholas J Hess, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
TIM-3 blockade enhances ex vivo stimulated allogeneic NK cell therapy for relapsed murine neuroblastoma after hematopoietic cell transplantAicha Quamine, Nicholas R Mohrdieck, Chloe A King, et al.
Journal for Immunotherapy of Cancer|December 12, 2025
TIM-3 blockade enhances ex vivo stimulated allogeneic NK cell therapy for relapsed murine neuroblastoma after hematopoietic cell transplantAicha E Quamine, Evan L Dray, Nicholas R Mohrdieck, et al.
Pageof 2